Dunno, but Jonnie Williams has been working with some researchers connected with Johns Hopkins to develop inhibitors of reactive oxygen species to treat autoimmune diseases.
Could be he has been buying back shares of Rock Creek to keep the Chapter 7 alive, with the intention of utilizing the former company as a vehicle for his new company, MYMD Pharmaceuticals.
Since the anatabine patents have been purchased by Philip Morris there is likely nothing in this for former Rock Creek shareholders.
News 
Market Data 
Discover 
